Cargando…
Human Cell Line-Derived Monoclonal IgA Antibodies for Cancer Immunotherapy
IgA antibodies have great potential to improve the functional diversity of current IgG antibody-based cancer immunotherapy options. However, IgA production and purification is not well established, which can at least in part be attributed to the more complex glycosylation as compared to IgG antibodi...
Autores principales: | Hart, Felix, Danielczyk, Antje, Goletz, Steffen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590476/ https://www.ncbi.nlm.nih.gov/pubmed/28952521 http://dx.doi.org/10.3390/bioengineering4020042 |
Ejemplares similares
-
Glyco-Engineered Anti-Human Programmed Death-Ligand 1 Antibody Mediates Stronger CD8 T Cell Activation Than Its Normal Glycosylated and Non-Glycosylated Counterparts
por: Goletz, Christoph, et al.
Publicado: (2018) -
Monoclonal IgA Antibodies for Aflatoxin Immunoassays
por: Ertekin, Özlem, et al.
Publicado: (2016) -
Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours
por: Fiedler, Walter, et al.
Publicado: (2018) -
KM55 Monoclonal Antibody and IgA Variant of Proliferative Glomerulonephritis With Monoclonal Ig Deposits
por: Zhang, Minfang, et al.
Publicado: (2020) -
Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies
por: Richards, Angelene F., et al.
Publicado: (2020)